关于我们
iNfinitesimal is a nanobiotechnology company that develops devices for targeted and controlled cellular delivery of biomolecules, drugs, nanoparticles, or other chemicals in liquid solution. Our mission is to enable precise cell access for gene editing and cellular therapies through the development of the first automated single cell transfection system leveraging proprietary NanoFountain Probe - Electroporation (NFP-E) technology licensed from Northwestern University.
- 网站
-
https://infinitesimal-llc.com
iNfinitesimal的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Skokie，IL
- 类型
- 私人持股
- 创立
- 2011
- 领域
- Single Cell Transfection、Electroporation、CRISPR/Cas9和Cell Line Generation
地点
-
主要
获取路线
8025 Lamon Ave.
Suite 70
US，IL，Skokie，60077